Indegene Limited

Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹510.90
Market cap
12,287 Cr
Stock P/E
31.7
P/B
3.91
Dividend yield
0.4%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales2,590 Cr677 Cr1,363 Cr720 Cr756 Cr761 Cr804 Cr942 Cr1,003 Cr
Operating expenses (approx.)2,006 Cr525 Cr1,064 Cr551 Cr583 Cr583 Cr644 Cr763 Cr849 Cr
EBITDA584 Cr151 Cr299 Cr170 Cr173 Cr177 Cr160 Cr179 Cr154 Cr
OPM %22.6%22.4%21.9%23.5%22.9%23.3%19.9%19.0%15.4%
Other income76 Cr23 Cr44 Cr38 Cr26 Cr22 Cr20 Cr19 Cr11 Cr
Interest49 Cr12 Cr16 Cr3 Cr3 Cr4 Cr4 Cr5 Cr7 Cr
Depreciation76 Cr20 Cr40 Cr20 Cr21 Cr22 Cr23 Cr40 Cr42 Cr
Profit before tax459 Cr120 Cr244 Cr146 Cr149 Cr152 Cr133 Cr135 Cr105 Cr
Tax %26.6%26.7%26.4%25.0%21.2%23.5%23.3%23.6%24.2%
Net profit337 Cr88 Cr179 Cr110 Cr118 Cr116 Cr102 Cr103 Cr80 Cr
EPS (₹)₹15.19₹3.79₹7.63₹4.59₹4.91₹4.86₹4.26₹4.29₹3.32

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales2,590 Cr2,839 Cr3,511 CrSign in for TTM
Operating expenses (approx.)2,082 Cr2,198 Cr2,840 CrSign in for TTM
EBITDA508 Cr642 Cr671 CrSign in for TTM
OPM %19.6%22.6%19.1%Sign in for TTM
Other income76 Cr107 Cr72 CrSign in for TTM
Interest49 Cr22 Cr19 CrSign in for TTM
Depreciation76 Cr80 Cr126 CrSign in for TTM
Profit before tax459 Cr539 Cr525 CrSign in for TTM
Tax %26.6%24.6%23.6%Sign in for TTM
Net profit337 Cr407 Cr401 CrSign in for TTM
EPS (₹)₹15.19₹17.15₹16.72Sign in for TTM
Dividend payout %0.0%0.0%12.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital44 Cr48 Cr48 Cr
Reserves1,385 Cr2,567 Cr3,091 Cr
Borrowings403 Cr——
Other liabilities713 Cr710 Cr1,482 Cr
Total liabilities2,546 Cr3,326 Cr4,620 Cr
Fixed assets (net)114 Cr135 Cr194 Cr
CWIP—4 Cr12 Cr
Investments797 Cr1,290 Cr1,100 Cr
Other assets1,791 Cr2,530 Cr2,618 Cr
Total assets2,546 Cr3,326 Cr4,620 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity508 Cr442 Cr651 Cr
Cash from investing-327 Cr-683 Cr-512 Cr
Cash from financing-66 Cr288 Cr-83 Cr
Net cash flow115 Cr52 Cr60 Cr
Free cash flow (OCF − Capex)497 Cr412 Cr607 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %23.6%21.5%17.3%
ROE %24.1%15.5%12.8%
Debtor days91——
Inventory days000
Days payable17——
Cash conversion cycle7500
Debt / equity0.28——
Current ratio2.934.482.41
Net debt / EBITDA0.42-0.38-0.45

Compare with peers

Loading peers…